Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
Jia-Han Ding(Fudan University Shanghai Cancer Center), Gen‐Hong Di(Shanghai Medical College of Fudan University), Ying Xu(Shenzhen University), Zhi‐Ming Shao(Fudan University), Yu-Ling Xiao(Shanghai Medical College of Fudan University), Shen Zhao(Sun Yat-sen University), Yi Xiao(Nanjing Medical University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University)
Cited by 40
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
|Signal Transduction and Targeted Therapy|2024|187
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
|Nature Communications|2018|183
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171